Infection Surveillance Solutions Market – Healthcare-acquired infections: prevention strategies, Market Size & Trends 2021 – expected to reach US$ 1,177.7 Mn With CAGR of 13.9% by 2027 | Coherent Market Insights - Medgadget
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/1699
The objective of CNISP was to control the healthcare-associated infections (HAIs) throughout Canada. Furthermore, between 2013 and 2014 Indian Council of Medical Research and the National Centre for Disease Control started Antimicrobial Resistance (AMR) Surveillance Networks. Moreover, pharmaceutical companies such as Pfizer, Inc. has shown interest in dealing with antimicrobial resistance. In January 2018, Pfizer, Inc. entered into partnership with Indian Council of Medical Research (ICMR) to combat antimicrobial resistance. AMR stewardship programs for nursing homes, scaling up of the AMR surveillance network will be the few key steps implemented by this partnership.
Infection Surveillance Solutions Market Drivers
Increasing prevalence of healthcare-acquired infections (HAIs) is expected to be the major driver for growth of the global infection surveillance solutions market. For instance, according to a HAI Prevalence Survey launched by Centers for Disease Control and Prevention in 2014, around 722,000 cases of HAIs were reported in the U.S. acute care hospitals and about 75,000 patients with HAIs died during their hospitalizations in 2011. Moreover, launch of novel and updated version of infection surveillance solutions is expected to fuel growth of the global infection surveillance solutions market over the forecast period. For instance, in 2015, Wolters Kluwer N.V. launched its updated version of Sentri7 electronic surveillance solution. Sentri7 is the improved version and will increase efficient and effective management of antimicrobials in hospitals and health systems. Adoption of infection surveillance solution by major hospitals is expected to create a lucrative environment for the growth of global infection surveillance solutions market in near future. For instance, in 2014, Ochsner Health System, a non-profit hospital deployed RL Solutions Infection Surveillance system namely RL6: Infection, throughout its eight facilities. RL6: Infection is a complete infection surveillance solution which provides real-time surveillance of a hospital's systems, including lab, ADT, pharmacy, surgery, EPR, and radiology.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/1699
Infection Surveillance Solutions Market Regional Analysis
North America is expected to hold a dominant position in global infection surveillance solutions market due to high adoption of infection surveillance solutions by hospitals in the U.S. and Canada. For instance, in 2014, Tucson Medical Center (TMC), a U.S.-based hospital installed infection surveillance solution from RL Solutions and in 2014, Trillium Health Partners, a Canada-based hospital installed RL Solutions' automated infection surveillance throughout its organization. Europe is expected to witness significant growth in global infection surveillance solutions market over the forecast period, owing to increasing prevalence of HAI's in region and adoption of infection surveillance solutions by hospitals. For instance, according to survey conducted by European Centre for Disease Prevention and Control (DCD), in 2013, it was estimated that the prevalence of HAI's in long-term care facilities was around 3.4% and around 4.2 million of HAI was estimated annually. Asia Pacific is expected to witness significant growth in near future due to increasing adoption of infection surveillance solutions by major hospitals in India. For instance, in 2016, Apollo Hospitals, a huge hospital chain in India adopted big data analytics to control hospital acquired infections in its hospital.
Infection Surveillance Solutions Restraints
High cost of infection surveillance software is the major factor that is expected to hinder growth of the global infection surveillance solutions market. Such high cost software are not affordable by local hospitals or by hospitals in emerging economies.
Infection Surveillance Solutions Market Key Players
Key players operating in the infection surveillance solutions market include RL Solutions, Wolters Kluwer N.V., ICNet International Limited, Baxter International Inc., Atlas Medical Software, Becton Dickinson and Company, Deb Group Ltd., Premier, Inc., Gojo Industries, Inc., Truven Health Analytics, and Hygreen, Inc., and others.
Key players in the market are focused on launching new software in market. For instance, in 2013, Alere Analytics, a subsidiary of Alere Inc. launched its new hospital clinical surveillance solution at 40th Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC). The new solution is an automated technology solution designed to manage antimicrobial stewardship, infection control and medication management.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/infection-surveillance-solutions-market-3499
Infection Surveillance Solutions Market Taxonomy:
The global infection surveillance solutions market is segmented on the basis of product type, end user, and region:
By Product Type-
- Software
- On-premise
- Web-based
- Services
By End User-
- Hospital
- Clinics
- Ambulatory Surgical Centers
- Others
By Region-
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Table of Content
Global Infection Surveillance Solutions Market Research Report
Section 1: Global Infection Surveillance Solutions Industry Overview
Section 2: Global Economic Impact on Infection Surveillance Solutions Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Infection Surveillance Solutions Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Infection Surveillance Solutions Market Forecast
Other Exclusive Reports:
Vaginal Fungi Infections Treatment Market To Surpass US$ 1,420.1 Million By 2027
Urinary Tract Infection Treatment Market To Reach US$ 11,827.8 Million By 2027
Blood Stream Infection Testing Market To Surpass US$ 7,728.4 Million By 2026
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Comments
Post a Comment